Sign Up to like & get
recommendations!
0
Published in 2018 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.577
Abstract: Vortioxetine is an antidepressant agent with multimodal activity that is approved for the treatment of major depressive disorder at doses of 5 to 20 mg once daily. Vortioxetine is a mediumâclearance drug that undergoes extensive…
read more here.
Keywords:
clinical pharmacokinetics;
pharmacokinetics vortioxetine;
factors clinical;
intrinsic factors ... See more keywords